paramagnetic contrast agents
Paramagnetic contrast agents are used to enhance MRI images and display areas of hypervascularity and associated pathology. They have their strongest effect in T1 weighted imaging because they predominantly alter the T1 relaxation time in the tissues in which they have accumulated.
MRI imaging relies upon the signal generated from the behavior of water protons. The relaxation of these water protons is affected by surrounding tissues and, when a paramagnetic contrast agent has been absorbed in its vicinity, the relaxation of water protons is enhanced.
The paramagnetic contrast agents generate a magnetic field 1000 times stronger than water protons. The interaction between the contrast agent and the water proton is exactly the same as the corresponding interactions with other molecules except that the magnitude of their magnetic interaction has a much greater effect on the relaxation time.
The primary class of paramagnetic contrast agent is gadolinium-based contrast agents. Others include ferric ammonium citrate and manganese-based contrast agents.
Related Radiopaedia articles
Physics and Imaging Technology: MRI
- MRI (introduction)
- MRI physics
- B0
- chemical shift
- dependence of magnetization (proton density, field strength and temperature)
- echo time
- eddy currents
- electromagnetic induction
- Ernst angle
- flip angle
- Larmor frequency
- magnetic dipolemagnetic field gradient
- magnetic susceptibility
- magnetism
- molecular tumbling rate effects on T1 and T2
- net magnetization vector (NMV)
- relaxation
- repetition time
- resonance and radiofrequency (RF)
- units of magnetism
- MRI hardware
- signal processing
- MRI pulse sequences (basics | abbreviations | parameters)
- CSF flow studies
- diffusion weighted sequences (DWI)
- echo-planar pulse sequences
- fat-suppressed imaging sequences
- gradient echo sequences
- inversion recovery sequences
- metal artifact reduction sequence (MARS)
- perfusion-weighted imaging
- techniques
- derived values
- saturation recovery sequences
- spin echo sequences
- spiral pulse sequences
- susceptibility-weighted imaging (SWI)
- T1 rho
- MR angiography (and venography)
- MR spectroscopy (MRS)
- 2-hydroxyglutarate peak: resonates at 2.25 ppm
- alanine peak: resonates at 1.48 ppm
- choline peak: resonates at 3.2 ppm
- citrate peak: resonates at 2.6 ppm
- creatine peak: resonates at 3.0 ppm
- functional MRI (fMRI)
- gamma-aminobutyric acid (GABA) peak: resonates at 2.2-2.4 ppm
- glutamine-glutamate peak: resonates at 2.2-2.4 ppm
- Hunter's angle
- lactate peak: resonates at 1.3 ppm
- lipids peak: resonates at 1.3 ppm
- myoinositol peak: resonates at 3.5 ppm
- MR fingerprinting
- N-acetylaspartate (NAA) peak: resonates at 2.0 ppm
- MRI artifacts
- MRI hardware and room shielding
- central point artifact
- herringbone artifact
- inhomogeneity artifact
- moiré fringes
- RF overflow artifact
- zebra stripes
- zipper artifact
- MRI software
- patient and physiologic motion
- tissue heterogeneity and foreign bodies
- Fourier transform and Nyquist sampling theorem
- MRI hardware and room shielding
- MRI contrast agents
- MRI safety